MADISON, Wis.--(BUSINESS WIRE)--TomoTherapy Incorporated (NASDAQ: TOMO) announced today that Addenbrooke’s Hospital of Cambridge, England, will install their second TomoTherapy® Hi·Art® radiation therapy system in 2009. During 2007, Addenbrooke’s was selected to be the first National Health Service (NHS) hospital in England to treat cancer patients with TomoTherapy’s unique, CT platform-based radiation therapy solution. The hospital competed against several prestigious hospitals in a bid to win a centralised, Government-funded Hi·Art treatment system for evaluation of the technology over a three-year period with the goal of advising on whether the new approach would have a future key role in the medical provision of radiation therapy in the UK’s publicly-funded NHS.
